METASTATIC UROTHELIAL CANCER
Clinical trials for METASTATIC UROTHELIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC UROTHELIAL CANCER trials appear
Sign up with your email to follow new studies for METASTATIC UROTHELIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to shrink advanced bladder cancer tumors
Disease control Recruiting nowThis study is testing a drug called sacituzumab govitecan, both by itself and combined with other treatments, for people with advanced bladder cancer that has spread and cannot be removed by surgery. The main goals are to see if the treatment shrinks tumors and is safe for patien…
Matched conditions: METASTATIC UROTHELIAL CANCER
Phase: PHASE2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New drug combo targets tough bladder cancers in global trial
Disease control Recruiting nowThis global study is testing a new drug called BT8009, both alone and combined with an existing immunotherapy (pembrolizumab), for people with advanced bladder cancer. It aims to see if these treatments can better control the cancer and extend life. The trial will enroll about 95…
Matched conditions: METASTATIC UROTHELIAL CANCER
Phase: PHASE2, PHASE3 • Sponsor: BicycleTx Limited • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC